Alto Neuroscience (ANRO) Exchange Rate Effect (2023 - 2026)
Alto Neuroscience (ANRO) reported Exchange Rate Effect of -$16000.0 for Q1 2026, up 27.27% on a YoY basis from -$12571.4 in Q1 2025, and down 1500.0% sequentially from -$1000.0 in Q4 2025.
Alto Neuroscience (ANRO) Exchange Rate Effect (2023 - 2026) Analysis & Trends
Alto Neuroscience (ANRO) has 4 years of Exchange Rate Effect data on file, last reported at -$16000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect rose 27.27% year-over-year to -$16000.0; the trailing twelve-month figure through Mar 2026 stood at -$24000.0 (up 14.29% YoY), and the FY2025 full-year result was -$30000.0, down 172.73% from the prior year.
- Exchange Rate Effect retreated to -$16000.0 in Q1 2026, from -$1000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $18000.0 in Q3 2023 to a low of -$22000.0 in Q1 2025.
- A 4-year average of -$5000.0 and a median of -$5000.0 in 2024 frame the typical range for Exchange Rate Effect.
- Across the five-year window, Exchange Rate Effect surged 73.68% in 2024 and tumbled 340.0% in 2025, its largest moves.
- Tracing ANRO's Exchange Rate Effect over 4 years: stood at $4000.0 in 2023, then jumped by 50.0% to $6000.0 in 2024, then tumbled by 116.67% to -$1000.0 in 2025, then tumbled by 1500.0% to -$16000.0 in 2026.
- Business Quant data shows ANRO's Exchange Rate Effect at -$16000.0 in Q1 2026, -$1000.0 in Q4 2025, and -$4000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 19.32 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Alto Neuroscience | 869.36 Mn | 869.36 Mn | - | -16,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16,000.00 |
| Mar 31, 2026 | -16,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Jun 30, 2025 | -3,000.00 |
| Jun 30, 2025 | -3,000.00 |
| Mar 31, 2025 | -22,000.00 |
| Mar 31, 2025 | -22,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Sep 30, 2024 | -7,000.00 |
| Sep 30, 2024 | -7,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Dec 31, 2023 | 4,000.00 |
| Dec 31, 2023 | 4,000.00 |